Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN146,8146,84-1,24
Msft0,10
Nokia9,96
IBM-0,95
Mercedes-Benz Group AG48,01548,0151,22
PFE0,15
13.06.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 12.06.2026
Stomil Sanok (SNK.WA, Warsaw)
Závěr k 12.6.2026 Změna (%) Změna (PLN) Objem obchodů (PLN)
21,30 0,00 0,00 22 586
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.06.2026
Popis společnosti

Business Summary: Sanok Rubber Company SA, known as Sanockie Zaklady Przemyslu Gumowego Stomil Sanok SA, is a Poland-based company focused on development, production and marketing of products made from rubber and rubber combined with metal and other materials. The Company’s business is divided into four segments: Automotive, Construction, Rubber Compounds and Industry and Agriculture. The Company manufactures a range of products used in such fields as car body sealing systems, car suspension and exhaust systems, electrical, power transmission, fuel and cooling systems, agriculture, household appliances and pharmaceutical industry.. The Company’s customers are: Fiat, General Motors, Ford Motor, Volvo Cars, Suzuki, Volkswagen Group, Volvo Trucks, Mack Truck and LDV, among others. The Company operates through Stomet Sp. z o.o., PST Stomil Sp. z o.o., Stomil Sanok Dystrybucja Sp. z o.o., PHU Stomil East Sp. z o.o., Stomil Sanok Wiatka satz, and Stomil Sanok Rus Sp. z o.o., among others.
Financial Summary: BRIEF: For the three months ended 31 March 2026, Sanok Rubber Company SA revenues increased 3% to PLN368.2M. Net income before extraordinary items decreased 18% to PLN6.5M. Revenues reflect Construction Industry segment increase of 19% to PLN49.9M, Blends segment increase of 23% to PLN39.1M, Others segment increase of 9% to PLN52.3M, Poland segment increase of 4% to PLN104.3M.



  • Poslední aktualizace: 14.06.2026
Management společnosti
Data nejsou k dispozici